Profile data is unavailable for this security.
About the company
Kilitch Drugs (India) Limited is an India-based pharmaceutical manufacturing company. The Company is mainly engaged in the development and operations of the pharmaceutical business. Its services range from manufacturing to marketing a host of formulations in all dosage forms. The Company offers products in the categories of Parenteral and Nasal Products, Oral, Effervescent, Nutritional Products, Medical Devices, and Cosmetics and Herbal Products. It offers products that help in gastroenterology, anti-inflammatory, anti-malaria, diagnostics, uterine stimulants, veterinary and many more areas in the form of ampoules & vials. Its range of oral formulations includes tablets, capsules, dry syrups and oral powders. It provides a range of cosmetics ranging from oil, lotion, liquid to cream and paste in the skin care, personal care and hair care categories. It offers a medical device, namely, the C-Seal. ROIPAR, ROIVIT, PH-7, C-SEAL, SRO-KIT, 9-VIT, HPURE are their product offerings.
- Revenue in INR (TTM)2.09bn
- Net income in INR279.59m
- Incorporated1992
- Employees187.00
- LocationKilitch Drugs (India) LtdVillage: SavroliTaluka: Khalapur, Dist: RaigadMUMBAI 400088IndiaIND
- Phone+91 2 261214100
- Fax+91 2 267031658
- Websitehttps://www.kilitch.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medico Remedies Ltd | 1.72bn | 113.47m | 3.90bn | 213.00 | 34.05 | 5.83 | 27.13 | 2.27 | 1.38 | 1.38 | 20.86 | 8.06 | 1.45 | 4.24 | 3.16 | 8,060,085.00 | 9.60 | 7.65 | 18.41 | 14.77 | 27.88 | 24.48 | 6.61 | 4.87 | 1.03 | 9.55 | 0.1578 | -- | 4.15 | 11.23 | 21.74 | 44.00 | -0.8645 | -- |
| Haleos Labs Ltd | 3.48bn | 198.49m | 3.93bn | 592.00 | 19.80 | -- | 10.81 | 1.13 | 65.66 | 65.66 | 1,150.43 | -- | -- | -- | -- | 5,874,455.00 | -- | 4.26 | -- | 7.05 | 37.48 | 32.35 | 6.02 | 4.76 | -- | 4.44 | -- | 2.85 | 12.67 | 5.74 | 121.15 | 14.58 | -8.05 | -- |
| Amanta Healthcare Ltd | -100.00bn | -100.00bn | 4.08bn | 506.00 | -- | 1.94 | -- | -- | -- | -- | -- | 54.26 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.34 | -- | 0.4687 | -- | -2.01 | -- | 189.02 | -- | -- | -- |
| Albert David Ltd | 3.23bn | 96.12m | 4.28bn | 1.81k | 44.55 | -- | 23.18 | 1.33 | 16.84 | 16.84 | 565.37 | -- | -- | -- | -- | 1,787,412.00 | -- | 8.95 | -- | 11.63 | 64.95 | 59.69 | 2.98 | 11.56 | -- | -4.67 | -- | 13.64 | -4.61 | 1.51 | -77.19 | -2.14 | -0.7463 | -6.51 |
| Medicamen Biotech Ltd | 1.65bn | 101.58m | 4.79bn | 376.00 | 45.04 | 1.63 | 32.27 | 2.90 | 7.84 | 7.84 | 121.55 | 216.61 | 0.5033 | 1.27 | 2.46 | 4,387,495.00 | 2.59 | 4.69 | 3.39 | 6.63 | 50.32 | 38.01 | 5.15 | 8.13 | 1.81 | 2.40 | 0.1231 | 10.57 | -9.35 | 5.31 | -34.97 | -11.77 | -35.60 | 14.87 |
| Kilitch Drugs (India) Ltd | 2.09bn | 279.59m | 5.72bn | 187.00 | 19.24 | 2.15 | 19.68 | 2.73 | 17.00 | 17.00 | 127.35 | 151.97 | 0.6366 | 14.84 | 2.55 | 11,200,870.00 | 8.06 | 5.16 | 10.47 | 7.38 | 35.71 | 35.37 | 12.66 | 8.41 | 2.37 | 4.80 | 0.2404 | 0.00 | 28.47 | 30.05 | 82.86 | 99.64 | 34.88 | -- |
| Shri Ahimsa Naturals Ltd | 1.16bn | 266.73m | 6.17bn | -- | 17.99 | 3.64 | 21.65 | 5.34 | 14.65 | 14.65 | 61.23 | 72.37 | 0.7957 | 1.80 | 4.75 | -- | 18.36 | 25.55 | 19.42 | 31.51 | 48.63 | 53.50 | 23.07 | 25.19 | 12.68 | -- | 0.00 | -- | 22.86 | 34.75 | 17.31 | 78.70 | 53.34 | -- |
| Anlon Healthcare Ltd | 1.70bn | 346.64m | 6.46bn | 101.00 | 16.49 | -- | 17.59 | 3.80 | 7.37 | 7.37 | 37.66 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 38.31 | -- | 20.39 | -- | -- | 11.05 | -- | -- | 80.65 | -- | 112.46 | -- | -- | -- |
| Kopran Ltd | 6.20bn | 165.43m | 6.48bn | 1.02k | 39.31 | -- | 19.41 | 1.05 | 3.41 | 3.41 | 128.28 | -- | -- | -- | -- | 6,052,426.00 | -- | 7.85 | -- | 11.25 | 34.20 | 32.04 | 2.67 | 8.66 | -- | 2.39 | -- | 29.60 | 2.44 | 11.86 | -24.34 | 12.90 | 33.20 | -- |
| Fabtech Technologies Ltd | -100.00bn | -100.00bn | 7.22bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 44.46 | -- | 70.67 | -- | -- | -- |
| Accent Microcell Ltd | 2.78bn | 346.64m | 7.72bn | 192.00 | 21.12 | 3.09 | 19.84 | 2.78 | 15.24 | 15.24 | 122.20 | 104.07 | 1.12 | 4.14 | 5.32 | 14,474,330.00 | 13.99 | -- | 15.95 | -- | 39.96 | -- | 12.47 | -- | 3.01 | 76.48 | 0.0046 | -- | 7.77 | -- | 9.60 | -- | -- | -- |
